Clinical Trial Update: HEMolysis in a Percutaneous Axial Flow LVAD, Effects of Pentoxifylline in a Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating pentoxifylline for hemolysis in patients with a percutaneous axial-flow left ventricular assist device has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Intravascular Hemolysis

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Hemolysis Intravascular, Acute Decompensated Heart Failure | Phase 4 | Status: WITHDRAWN